| Literature DB >> 36247124 |
Wenxiang Yang1, Ji Liu2, Yanhua Zheng1, Jingjing Qu1, Xiaoqiao Tang1, Hong Bai2, Chunxia Liu1, Bolin Fan1.
Abstract
Objective: The purpose of this study was to evaluate the safety of rhubarb extract.Entities:
Keywords: Chronic toxicity; Rhubarb extract; Sprague-Dawley rats
Year: 2022 PMID: 36247124 PMCID: PMC9557872 DOI: 10.1016/j.heliyon.2022.e10907
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1Weekly mean body weights of females (A)and males rats (B); Weekly mean food consumption of females (C)and males rats (D).
The proportion of samples incorporated into the diet.
| Groups | Dose (mg/kg) | Incorporation ratio of rhubarb extract in the diet (%) | Number of animals |
|---|---|---|---|
| 0 mg/kg | 0 | 0 | 20M/20F |
| 101 mg/kg | 101 | 0.126 | 20M/20F |
| 405 mg/kg | 405 | 0.506 | 20M/20F |
| 1620 mg/kg | 1620 | 2.025 | 20M/20F |
Note: 3 months before the test, the sample amount incorporated into the diet was calculated based on the fed to body weight ratio of 8%, and then the sample incorporation ratio was adjusted according to the actual fed amount.
Body weight of S-D rats orally administrated with Rhubarb Extract for 52 weeks.
| Weeks | Female | Male | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | 0 mg/kg | 101 mg/kg | 405 mg/kg | 1620 mg/kg | n | 0 mg/kg | 101 mg/kg | 405 mg/kg | 1620 mg/kg | |
| 0 | 20 | 69.8 ± 5.8 | 70.7 ± 5.4 | 70 ± 6.7 | 69.9 ± 4.7 | 20 | 81.6 ± 4.8 | 80.7 ± 6.2 | 81.5 ± 5.2 | 80.7 ± 4.9 |
| 1 | 20 | 117.8 ± 6.9 | 114.4 ± 9.6 | 107.8 ± 16 | 111.5 ± 6.8∗ | 20 | 138.9 ± 7.4 | 134.9 ± 10.6 | 131 ± 9.6∗∗ | 125.4 ± 9.5∗∗ |
| 2 | 20 | 153.3 ± 9.4 | 152.9 ± 14.7 | 149.9 ± 11.8 | 150 ± 11.3 | 20 | 197.3 ± 10.8 | 199 ± 10.9 | 194.3 ± 13.8 | 195.5 ± 11.8 |
| 3 | 20 | 178.2 ± 9.6 | 173.8 ± 16.7 | 170 ± 12.7 | 169.6 ± 12.3∗ | 20 | 249.7 ± 14.7 | 247.6 ± 13.1 | 242.3 ± 16.5 | 233.3 ± 17.2∗∗ |
| 4 | 20 | 199.8 ± 11.2 | 199.3 ± 19.9 | 193.6 ± 15.9 | 195.5 ± 17.5 | 20 | 291.1 ± 17.1 | 294.3 ± 15.7 | 284.7 ± 19 | 270.3 ± 19.7∗∗ |
| 5 | 20 | 220.5 ± 11.8 | 220.4 ± 22 | 215.8 ± 15.3 | 216.7 ± 16.8 | 20 | 327 ± 21.3 | 326.8 ± 20.3 | 321.9 ± 21.4 | 309.8 ± 23.2∗ |
| 6 | 20 | 237.8 ± 11.7 | 239.3 ± 23 | 236.4 ± 17.9 | 228 ± 17.4 | 20 | 361 ± 28.7 | 362.1 ± 21.7 | 357.6 ± 22.9 | 334.3 ± 24.4∗∗ |
| 7 | 20 | 253.7 ± 13.6 | 261 ± 26.2 | 253.4 ± 20.7 | 243 ± 14.9 | 20 | 398.3 ± 28.6 | 404.4 ± 25.2 | 396.5 ± 25.4 | 369.3 ± 27.7∗∗ |
| 8 | 20 | 261.9 ± 16.3 | 274.2 ± 28.9 | 264.7 ± 23.7 | 253.6 ± 18.9 | 20 | 422.2 ± 29.4 | 428 ± 24.5 | 427 ± 29.4 | 388.3 ± 29.6∗∗ |
| 9 | 20 | 267 ± 14.3 | 281 ± 28.2 | 270.1 ± 24.3 | 258.2 ± 20.9∗ | 20 | 442.9 ± 29.7 | 452.5 ± 28.4 | 447 ± 31.2 | 408.5 ± 31.3∗∗ |
| 10 | 20 | 280.7 ± 15.2 | 291.9 ± 31.3 | 282.9 ± 28.2 | 265.8 ± 21.1∗ | 20 | 468.5 ± 29.2 | 478.6 ± 30.5 | 467.5 ± 32.6 | 430.6 ± 33.3∗∗ |
| 11 | 20 | 286.2 ± 17.7 | 298.5 ± 30.8 | 289 ± 25.9 | 269.7 ± 20.1∗∗ | 20 | 486.9 ± 30.8 | 494.3 ± 32.2 | 486.2 ± 35.3 | 441.4 ± 34.7∗∗ |
| 12 | 20 | 293.2 ± 19.4 | 306.8 ± 32.7 | 293.9 ± 32.3 | 279.9 ± 21.8∗ | 20 | 506.9 ± 32.1 | 513 ± 35.6 | 504.9 ± 38.2 | 461.8 ± 35.8∗∗ |
| 13 | 20 | 299 ± 18.8 | 317.6 ± 33.6 | 304.4 ± 30.9 | 283 ± 22.7∗ | 20 | 516.1 ± 32.1 | 532.3 ± 35.2 | 514.9 ± 39.2 | 473.4 ± 39.4∗∗ |
| 17 | 20 | 322 ± 22.6 | 340 ± 32.7 | 324.4 ± 33.4 | 298.2 ± 25.1∗ | 20 | 573.2 ± 35.7 | 587 ± 36.2 | 570 ± 47.3 | 523.1 ± 45.9∗∗ |
| 21 | 20 | 329.9 ± 22.5 | 354.2 ± 35.4 | 334.6 ± 35.7 | 305.8 ± 25.4∗ | 20 | 613 ± 35.3 | 632.6 ± 38.2 | 610.6 ± 49.3 | 555.1 ± 48.2∗∗ |
| 25 | 20 | 344.1 ± 21.4 | 356 ± 37.8 | 339.7 ± 38.6 | 310.3 ± 26.4∗∗ | 20 | 641.4 ± 40.5 | 654.3 ± 44.1 | 634.5 ± 54.7 | 569.8 ± 51.1∗∗ |
| 29 | 20 | 356.8 ± 23.2 | 364.8 ± 38.9 | 344.1 ± 33.8 | 320.1 ± 29.5∗∗ | 20 | 672 ± 43.2 | 681.5 ± 43.4 | 651.6 ± 55.1 | 573.8 ± 51∗∗ |
| 33 | 20 | 380.8 ± 24.3 | 394.3 ± 48.3 | 362.2 ± 35.9 | 339.8 ± 33.1∗∗ | 20 | 704.8 ± 46.1 | 714.4 ± 41.5 | 687.7 ± 62.5 | 597.6 ± 55.4∗∗ |
| 37 | 19 | 384.6 ± 24.9 | 405.1 ± 55.3 | 372.3 ± 42.5 | 339.7 ± 36.6∗∗ | 20 | 723.8 ± 48.6 | 738.5 ± 44.5 | 702.8 ± 63 | 610.4 ± 56.9∗∗ |
| 41 | 19 | 388.2 ± 31 | 414.2 ± 58.8 | 375.7 ± 38.6 | 341.4 ± 35.7∗∗ | 20 | 752.2 ± 52.6 | 764.9 ± 49.3 | 717.9 ± 64.3 | 633.3 ± 58.6∗∗ |
| 45 | 19 | 390.8 ± 31.2 | 413.9 ± 66.1 | 373.7 ± 34.7 | 344.3 ± 38.3∗∗ | 20 | 772.5 ± 55 | 786.2 ± 51.4 | 730.2 ± 64.5∗ | 642.2 ± 58.5∗∗ |
| 49 | 19 | 397.9 ± 33.1 | 422.7 ± 68.9 | 381.3 ± 31.2 | 350.5 ± 37.4∗∗ | 20 | 796.1 ± 59.5 | 805.4 ± 51.2 | 757.4 ± 67∗ | 663.4 ± 60.4∗∗ |
| 53 | 19 | 401.3 ± 37.4 | 427.5 ± 73.9 | 383.4 ± 36.4 | 355.8 ± 39.4∗∗ | 20 | 805.4 ± 59.4 | 810.9 ± 56.6 | 756.8 ± 64.3∗ | 656.1 ± 81.8∗∗ |
Compared with the control group. ∗: P < 0.05. ∗: P < 0.01.
Food consumer of S-D orally administrated rats with Rhubarb Extract for 52 weeks.
| Weeks | Female | Male | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | 0 mg/kg | 101 mg/kg | 405 mg/kg | 1620 mg/kg | n | 0 mg/kg | 101 mg/kg | 405 mg/kg | 1620 mg/kg | |
| 1W | 20 | 15.5 ± 1.3 | 14.7 ± 1.6 | 13.5 ± 1.5∗∗ | 14.0 ± 1.3∗∗ | 20 | 17.6 ± 0.7 | 17.5 ± 1.4 | 17.1 ± 1.7 | 17.0 ± 1.7 |
| 2W | 20 | 17.1 ± 1.1 | 16.6 ± 0.8 | 16.2 ± 1.4∗ | 15.9 ± 1.0∗∗ | 20 | 20.4 ± 0.9 | 21.6 ± 0.8∗∗ | 21.3 ± 1.0∗∗ | 22.1 ± 1.0∗∗ |
| 3W | 20 | 15.4 ± 1.9 | 15.4 ± 1.9 | 14.8 ± 1.6 | 15.0 ± 1.6 | 20 | 22.1 ± 1.0 | 23.7 ± 1.6∗∗ | 21.6 ± 0.8 | 20.6 ± 1.8∗ |
| 4W | 20 | 16.5 ± 1.2 | 17.5 ± 0.9∗∗ | 17.4 ± 1.1∗ | 17.7 ± 1.4∗∗ | 20 | 24.7 ± 1.0 | 25.6 ± 1.1∗ | 29.1 ± 4.6 | 24.0 ± 0.9∗∗ |
| 5W | 20 | 18.0 ± 1.0 | 18.1 ± 0.9 | 18.5 ± 1.2 | 20.5 ± 1.6∗∗ | 20 | 24.5 ± 1.8 | 26.5 ± 2.1∗ | 25.8 ± 1.1 | 25.1 ± 1.3 |
| 6W | 20 | 18.9 ± 1.4 | 21.6 ± 3.6∗ | 19.3 ± 1.6 | 20.1 ± 0.7∗ | 20 | 25.6 ± 1.0 | 27.1 ± 1.6∗∗ | 26.8 ± 1.4∗∗ | 25.9 ± 1.4 |
| 7W | 20 | 18.4 ± 3.0 | 21.2 ± 4.8∗ | 18.3 ± 3.2 | 18.7 ± 2.8 | 20 | 28.7 ± 2.7 | 30.3 ± 3.0 | 29.0 ± 3.2 | 30.0 ± 5.1 |
| 8W | 20 | 19.8 ± 3.2 | 21.2 ± 3.1 | 20.6 ± 3.0 | 21.0 ± 3.1 | 20 | 27.4 ± 2.0 | 29.1 ± 2.9 | 29.1 ± 3.0 | 30.7 ± 4.6∗ |
| 9W | 20 | 18.2 ± 1.7 | 20.3 ± 3.9 | 19.8 ± 2.8 | 20.4 ± 3.4 | 20 | 27.8 ± 3.2 | 29.3 ± 3.0 | 28.6 ± 3.6 | 29.7 ± 4.2 |
| 10W | 20 | 19.9 ± 2.6 | 21.5 ± 3.5 | 20.3 ± 2.5 | 20.1 ± 2.7 | 20 | 28.5 ± 2.3 | 27.8 ± 3.4 | 28.0 ± 4.1 | 29.7 ± 3.2 |
| 11W | 20 | 18.8 ± 3.1 | 19.8 ± 3.6 | 18.8 ± 4.7 | 21.4 ± 3.6∗ | 20 | 30.0 ± 2.5 | 28.7 ± 6.3 | 29.0 ± 3.2 | 32.0 ± 2.6 |
| 12W | 20 | 18.9 ± 2.4 | 21.8 ± 2.3∗∗ | 19.0 ± 3.0 | 21.6 ± 4.2 | 20 | 30.5 ± 2.7 | 31.7 ± 3.1 | 30.3 ± 5.1 | 34.1 ± 3.9∗∗ |
| 13W | 20 | 18.0 ± 2.2 | 18.5 ± 4.0 | 20.5 ± 3.1 | 20.7 ± 4.1 | 20 | 28.6 ± 2.8 | 29.6 ± 4.1 | 30.5 ± 3.3 | 33.9 ± 4.3 |
| 14W | 20 | 18.5 ± 2.4 | 17.8 ± 3.6 | 18.8 ± 3.2∗ | 18.2 ± 3.0∗ | 20 | 27.8 ± 2.3 | 27.7 ± 5.4 | 28.2 ± 3.4 | 28.8 ± 3.3∗∗ |
| 17W | 20 | 18.6 ± 2.8 | 17.6 ± 2.9 | 17.2 ± 2.2 | 18.7 ± 3.2 | 20 | 26.1 ± 2.4 | 28.6 ± 3.1∗ | 26.0 ± 3.0 | 28.3 ± 3.8∗ |
| 21W | 20 | 18.0 ± 1.9 | 18.2 ± 3.4 | 18.4 ± 3.8 | 19.7 ± 2.8 | 20 | 26.5 ± 2.9 | 30.7 ± 2.8∗∗ | 29.2 ± 2.8∗ | 29.6 ± 4.1 |
| 25W | 20 | 19.4 ± 2.8 | 18.0 ± 3.9 | 16.9 ± 3.3∗ | 21.5 ± 2.8∗ | 20 | 29.4 ± 2.3 | 29.6 ± 2.5 | 27.6 ± 4.1 | 32.1 ± 3.5∗ |
| 29W | 20 | 18.7 ± 2.2 | 19.8 ± 3.0 | 19.8 ± 2.7 | 20.2 ± 3.0 | 20 | 29.0 ± 3.0 | 29.1 ± 3.0 | 29.4 ± 4.3 | 31.9 ± 5.3 |
| 33W | 20 | 17.0 ± 3.2 | 18.8 ± 3.3 | 19.9 ± 3.4∗∗ | 19.3 ± 3.8∗ | 20 | 26.7 ± 2.8 | 28.2 ± 2.9 | 28.6 ± 3.3 | 30.5 ± 4.4∗∗ |
| 37W | 20 | 14.0 ± 2.6 | 17.4 ± 3.5∗∗ | 17.9 ± 2.4∗∗ | 16.6 ± 2.9∗∗ | 20 | 27.9 ± 3.1 | 28.2 ± 3.1 | 27.7 ± 4.1 | 29.2 ± 5.8 |
| 41W | 20 | 16.7 ± 2.6 | 16.4 ± 2.6 | 18.4 ± 2.7 | 20.2 ± 3.7∗∗ | 20 | 27.2 ± 3.0 | 28.0 ± 2.8 | 28.3 ± 3.6 | 30.7 ± 4.9∗∗ |
| 45W | 20 | 16.3 ± 2.8 | 16.1 ± 3.3 | 16.9 ± 1.6 | 20.0 ± 3.1∗∗ | 20 | 27.8 ± 3.8 | 28.3 ± 2.7 | 29.7 ± 4.7 | 31.9 ± 3.7∗∗ |
| 49W | 20 | 21.3 ± 3.3 | 22.2 ± 3.7 | 21.0 ± 2.6 | 21.9 ± 3.0 | 20 | 30.8 ± 2.9 | 29.2 ± 3.3 | 30.7 ± 3.4 | 32.6 ± 7.5 |
Compared with the control group. ∗: P < 0.05. ∗: P < 0.01.
Hematology parameters of S-D orally administrated rats with Rhubarb Extract for 52 weeks.
| Parameters | Female | Male | ||||||
|---|---|---|---|---|---|---|---|---|
| 0 mg/kg | 101 mg/kg | 405 mg/kg | 1620 mg/kg | 0 mg/kg | 101 mg/kg | 405 mg/kg | 1620 mg/kg | |
| WBC(×109/L) | 1.9 ± 0.7 | 2.4 ± 0.7∗ | 2.3 ± 0.6 | 2.9 ± 1.1∗∗ | 4.0 ± 1.5 | 5.7 ± 2.6 | 4.6 ± 2.1 | 5.7 ± 8.3 |
| RBC(×1012/L) | 7.01 ± 0.21 | 7.20 ± 0.44 | 7.31 ± 0.33 | 7.07 ± 0.32 | 8.10 ± 0.40 | 7.96 ± 0.55 | 8.06 ± 0.44 | 8.03 ± 0.54 |
| HGB (g/L) | 132 ± 3 | 134 ± 7 | 132 ± 4 | 129 ± 6 | 138 ± 4 | 136 ± 11 | 138 ± 4 | 134 ± 6 |
| HCT (%) | 39.7 ± 1.1 | 40.5 ± 2.2 | 40.0 ± 1.5 | 39.6 ± 2.1 | 41.5 ± 1.2 | 41.0 ± 3.0 | 41.1 ± 1.1 | 40.3 ± 1.8 |
| PLT (103/L) | 991 ± 129 | 969 ± 132 | 1011 ± 97 | 969 ± 101 | 1313 ± 148 | 1228 ± 125 | 1279 ± 124 | 1219 ± 145∗ |
| MCV(fL) | 56.6 ± 1.7 | 56.4 ± 2.2 | 56.1 ± 1.7 | 56.0 ± 2.4 | 51.3 ± 3.2 | 51.5 ± 3.0 | 51.1 ± 2.8 | 50.3 ± 2.5 |
| MCH(pg) | 18.8 ± 0.4 | 18.7 ± 0.6 | 18.6 ± 0.5 | 18.3 ± 0.6∗∗ | 17.1 ± 1.0 | 17.1 ± 0.9 | 17.2 ± 0.08 | 16.7 ± 0.8 |
| MCHC(g/L) | 332 ± 4 | 331 ± 4 | 331 ± 4 | 327 ± 5∗∗ | 333 ± 5 | 331 ± 7 | 336 ± 5 | 332 ± 5 |
| NEUT (%) | 28.8 ± 5.7 | 27.3 ± 4.2 | 28.9 ± 9.0 | 32.4 ± 11.2 | 36.7 ± 9.4 | 39.4 ± 12.6 | 37.9 ± 14.3 | 41.5 ± 9.4 |
| LYMPH(%) | 67.1 ± 6.1 | 68.2 ± 5.0 | 67.2 ± 9.3 | 64.0 ± 11.2 | 59.1 ± 9.6 | 56.7 ± 12.5 | 58.4 ± 14.2 | 54.4 ± 9.4∗ |
| MONO(%) | 1.4 ± 0.9 | 1.8 ± 0.8 | 1.5 ± 0.8 | 1.5 ± 0.6 | 2.2 ± 0.8 | 2.2 ± 0.8 | 1.9 ± 0.6 | 2.6 ± 1.3 |
| EO (%) | 2.7 ± 0.8 | 2.7 ± 1.1 | 2.4 ± 0.8 | 2.1 ± 0.8∗ | 2.1 ± 0.7 | 1.7 ± 0.6 | 1.7 ± 0.7 | 1.7 ± 0.7∗ |
| NEUT# | 0.54 ± 0.20 | 0.56 ± 0.17 | 0.67 ± 0.29 | 0.93 ± 0.46∗ | 1.44 ± 0.63 | 2.24 ± 1.62∗ | 1.82 ± 1.37 | 1.54 ± 0.35 |
| LYMPH# | 1.30 ± 0.55 | 1.67 ± 0.55 | 1.56 ± 0.50 | 1.84 ± 0.82∗∗ | 2.36 ± 1.02 | 3.22 ± 1.55∗ | 2.59 ± 1.22 | 2.20 ± 1.02 |
| MONO# | 0.03 ± 0.02 | 0.04 ± 0.02∗ | 0.04 ± 0.02 | 0.05 ± 0.03∗ | 0.09 ± 0.05 | 0.13 ± 0.10 | 0.09 ± 0.06 | 0.24 ± 0.66 |
| EO# | 0.05 ± 0.02 | 0.06 ± 0.02∗ | 0.05 ± 0.02 | 0.06 ± 0.03 | 0.08 ± 0.04 | 0.09 ± 0.04 | 0.08 ± 0.05 | 0.07 ± 0.03 |
| RET# | 0.11 ± 0.02 | 0.12 ± 0.03 | 0.11 ± 0.03 | 0.12 ± 0.03 | 0.16 ± 0.03 | 0.16 ± 0.03 | 0.15 ± 0.02 | 0.14 ± 0.02∗∗ |
| RET (%) | 1.53 ± 0.32 | 1.65 ± 0.35 | 1.59 ± 0.39 | 1.71 ± 0.39 | 2.00 ± 0.34 | 1.98 ± 0.45 | 1.89 ± 0.29 | 1.78 ± 0.22∗ |
| APTT(s) | 13.5 ± 1.7 | 13.1 ± 1.1 | 13.7 ± 1.6 | 13.8 ± 2.0 | 12.9 ± 2.2 | 12.9 ± 2.1 | 13.1 ± 1.7 | 13.7 ± 2.5 |
| PT(s) | 12.7 ± 0.3 | 12.6 ± 0.4 | 12.8 ± 0.6 | 12.8 ± 0.4 | 12.7 ± 0.7 | 12.8 ± 0.6 | 13.1 ± 0.8 | 12.9 ± 0.5 |
Compared with the control group. ∗: P < 0.05. ∗: P < 0.01, n = 20(Female, 1620 mg/kg group n = 19).
Clinical biochemistry parameters of S-D rats orally administrated with Rhubarb Extract for 52 weeks.
| Parameters | Female | Male | ||||||
|---|---|---|---|---|---|---|---|---|
| 0 mg/kg | 101 mg/kg | 405 mg/kg | 1620 mg/kg | 0 mg/kg | 101 mg/kg | 405 mg/kg | 1620 mg/kg | |
| GGT (U/L) | 51.68 ± 15.13 | 46.87 ± 13.48 | 49.67 ± 24.50 | 56.83 ± 20.72 | 94.94 ± 22.76 | 86.35 ± 25.94 | 90.05 ± 25.30 | 87.30 ± 28.41 |
| ALT (U/L) | 26 ± 6 | 25 ± 6 | 25 ± 5 | 22 ± 4∗ | 36 ± 11 | 34 ± 9 | 32 ± 7 | 28 ± 8∗∗ |
| AST (U/L) | 86 ± 36 | 79 ± 23 | 77 ± 23 | 72 ± 9 | 118 ± 64 | 103 ± 22 | 97 ± 21 | 107 ± 64 |
| TP (g/L) | 65.9 ± 2.7 | 65.3 ± 2.0 | 65.9 ± 3.7 | 65.6 ± 4.7 | 62.5 ± 1.7 | 63.5 ± 2.4 | 61.7 ± 2.1 | 60.0 ± 1.8∗∗ |
| ALB (g/L) | 36.1 ± 1.7 | 35.3 ± 1.4 | 35.8 ± 2.1 | 36.4 ± 2.3 | 29.8 ± 1.1 | 29.6 ± 2.3 | 29.1 ± 1.2 | 28.9 ± 1.3 |
| A/G | 1.21 ± 0.07 | 1.18 ± 0.08 | 1.19 ± 0.06 | 1.25 ± 0.06 | 0.91 ± 0.05 | 0.88 ± 0.10 | 0.90 ± 0.05 | 0.93 ± 0.06 |
| TBIL (μmol/L) | 2.5 ± 1.2 | 2.3 ± 1.2 | 1.19 ± 0.07 | 2.4 ± 1.1 | 1.6 ± 1.1 | 1.6 ± 0.9 | 1.9 ± 1.1 | 1.5 ± 0.7 |
| ALP(U/L) | 28 ± 15 | 22 ± 7 | 25 ± 10 | 28 ± 12 | 43 ± 12 | 48 ± 18 | 40 ± 11 | 43 ± 14 |
| GLU (mmol/L) | 6.51 ± 0.58 | 6.40 ± 0.43 | 6.19 ± 0.60 | 7.32 ± 4.49 | 9.29 ± 1.85 | 9.12 ± 1.99 | 9.19 ± 1.29 | 7.53 ± 1.10∗∗ |
| BUN(mmol/L) | 3.49 ± 0.50 | 3.45 ± 0.65 | 3.35 ± 0.46 | 3.12 ± 0.38∗ | 3.79 ± 0.38 | 3.47 ± 0.33∗ | 3.76 ± 0.60 | 3.42 ± 0.48∗ |
| CREA (μmol/L) | 76.4 ± 5.1 | 73.5 ± 5.6 | 71.7 ± 3.9∗ | 72.5 ± 8.0∗ | 75.0 ± 5.1 | 71.9 ± 7.0 | 74.7 ± 7.2 | 71.1 ± 7.3 |
| CHOl (mmol/L) | 1.65 ± 0.38 | 1.72 ± 0.52 | 1.79 ± 0.39 | 1.63 ± 0.26 | 1.50 ± 0.61 | 1.39 ± 0.35 | 1.48 ± 0.47 | 1.10 ± 0.20∗∗ |
| TG (mmol/L) | 0.65 ± 0.31 | 0.58 ± 0.20 | 0.57 ± 0.34 | 0.35 ± 0.20∗∗ | 0.87 ± 0.39 | 0.74 ± 0.27 | 0.75 ± 0.56 | 0.68 ± 0.25 |
| CK(U/L) | 233 ± 390 | 164 ± 266 | 158 ± 361 | 112 ± 102 | 223 ± 277 | 168 ± 185 | 164 ± 167 | 126 ± 142 |
| CHE(U/L) | 1093 ± 101 | 1077 ± 81 | 1085 ± 90 | 1104 ± 88 | 761 ± 36 | 762 ± 17 | 758 ± 24 | 745 ± 15∗ |
| LDH(U/L) | 1048 ± 260 | 889 ± 299 | 783 ± 189∗∗ | 725 ± 332∗∗ | 1298 ± 534 | 1074 ± 347 | 959 ± 238 | 994 ± 430 |
| K+(mmol/L) | 3.67 ± 0.24 | 3.84 ± 0.36 | 3.71 ± 0.32 | 4.28 ± 2.52 | 4.61 ± 0.35 | 4.74 ± 0.30 | 4.67 ± 0.44 | 4.65 ± 0.26 |
| Na+(mmol/L) | 136.6 ± 1.3 | 137.6 ± 1.2∗ | 137.1 ± 0.9 | 137.1 ± 1.4 | 142.0 ± 2.4 | 143.1 ± 1.2 | 142.8 ± 1.6 | 143.1 ± 1.7∗ |
| Cl-(mmol/L) | 100.0 ± 2.1 | 100.2 ± 1.9 | 99.7 ± 1.2 | 100.2 ± 1.8 | 104.9 ± 1.9 | 104.6 ± 1.8 | 104.4 ± 1.6 | 104.5 ± 2.1 |
| Ca+(mmol/L) | 2.52 ± 0.08 | 2.55 ± 0.07 | 2.55 ± 0.07 | 2.57 ± 0.16 | 2.51 ± 0.06 | 2.50 ± 0.05 | 2.50 ± 0.05 | 2.48 ± 0.05 |
| P+(mmol/L) | 1.43 ± 0.18 | 1.66 ± 0.17∗ | 1.64 ± 0.16∗ | 1.75 ± 0.49∗ | 2.00 ± 0.26 | 2.12 ± 0.40 | 2.14 ± 0.28 | 2.10 ± 0.20 |
Compared with the control group. ∗: P < 0.05. ∗: P < 0.01, n = 20(Female, 1620 mg/kg group n = 19).
Urinalysis parameters of S-D rats orally administrated with Rhubarb Extract for 52 weeks.
| Item | Degree | Female | Male | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 0 mg/kg | 101 mg/kg | 405 mg/kg | 1620 mg/kg | 0 mg/kg | 101 mg/kg | 405 mg/kg | 1620 mg/kg | ||
| pH | 6 | 0 | 4 | 2 | 0 | 0 | 0 | 0 | 2 |
| 6.5 | 16 | 8 | 14 | 14 | 2 | 2 | 8 | 18∗∗ | |
| 7 | 4 | 4 | 3 | 4 | 10 | 11 | 9 | 0 | |
| 7.5 | 0 | 3 | 1 | 1 | 7 | 7 | 2 | 0 | |
| 8 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | |
| 8.5 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
| Pro | - | 14 | 11 | 15 | 8 | 0 | 0 | 0 | 0 |
| +- | 4 | 7 | 5 | 2 | 1 | 0 | 0 | 2 | |
| 1+ | 1 | 2 | 0 | 8 | 3 | 3 | 6 | 2 | |
| 2+ | 1 | 0 | 0 | 1 | 5 | 5 | 6 | 13 | |
| 3+ | 0 | 0 | 0 | 0 | 11 | 12 | 8 | 3 | |
| GLU | - | 20 | 20 | 20 | 19 | 20 | 20 | 20 | 20 |
| NIT | - | 20 | 20 | 19 | 8 | 16 | 12 | 19 | 4 |
| + | 0 | 0 | 1 | 11∗∗ | 4 | 8 | 1 | 16∗∗ | |
| BLD | - | 19 | 20 | 20 | 7 | 10 | 11 | 10 | 5 |
| +- | 0 | 0 | 0 | 0 | 4 | 3 | 2 | 3 | |
| 1+ | 1 | 0 | 0 | 0 | 1 | 0 | 5 | 11 | |
| 2+ | 0 | 0 | 0 | 3 | 3 | 2 | 0 | 1 | |
| 3+ | 0 | 0 | 0 | 9∗∗ | 2 | 4 | 3 | 0 | |
| BIL | - | 20 | 20 | 20 | 19 | 20 | 20 | 20 | 17 |
| 1+ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | |
| WBC | - | 16 | 9 | 13 | 0 | 0 | 0 | 0 | 0 |
| +- | 3 | 9 | 6 | 9 | 0 | 0 | 0 | 0 | |
| 1+ | 1 | 2 | 1 | 9 | 2 | 1 | 5 | 19 | |
| 2+ | 0 | 0 | 0 | 1 | 2 | 3 | 6 | 1 | |
| 3+ | 0 | 0 | 0 | 0∗∗ | 16 | 16 | 9 | 0∗∗ | |
| KET | - | 16 | 0∗∗ | 17 | 7∗ | 4 | 0 | 0 | 3 |
| +- | 4 | 19 | 3 | 13 | 15 | 3 | 17 | 12∗∗ | |
| 1+ | 0 | 0 | 0 | 0 | 1 | 17 | 3 | 5 | |
| UBG | Normal | 20 | 20 | 20 | 19 | 20 | 20 | 20 | 20 |
Compared with the control group. ∗: P < 0.05. ∗: P < 0.01, n = 20(Female, 1620 mg/kg group n = 19).
Relative organ weights to brain (%)of S-D rats orally administrated with Rhubarb Extract for 52 weeks.
| Sex | Numbers of Animals | Dose | Heart | Lung | Liver | Spleen | Kidney | Ovaries/Testes | Uterus/Epididymides | Adrenals | Thymus |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Female | 20 | 0 | 0.62 ± 0.07 | 0.76 ± 0.09 | 4.88 ± 0.46 | 0.33 ± 0.04 | 1.18 ± 0.10 | 0.089 ± 0.036 | 0.47 ± 0.09 | 0.057 ± 0.012 | 0.22 ± 0.08 |
| 20 | 101 | 0.63 ± 0.08 | 0.88 ± 0.19 | 5.10 ± 0.85 | 0.38 ± 0.08 | 1.23 ± 0.11 | 0.087 ± 0.017 | 0.43 ± 0.09 | 0.058 ± 0.015 | 0.26 ± 0.12 | |
| 20 | 405 | 0.61 ± 0.1 | 0.80 ± 0.10 | 4.86 ± 0.54 | 0.36 ± 0.06 | 1.23 ± 0.13 | 0.102 ± 0.028 | 0.44 ± 0.10 | 0.051 ± 0.010 | 0.19 ± 0.06 | |
| 19 | 1620 | 0.61 ± 0.13 | 0.81 ± 0.16 | 4.68 ± 0.85 | 0.39 ± 0.07∗ | 1.28 ± 0.19∗ | 0.090 ± 0.016 | 0.46 ± 0.10 | 0.058 ± 0.011 | 0.16 ± 0.06 | |
| Male | 20 | 0 | 0.99 ± 0.11 | 1.10 ± 0.15 | 9.37 ± 1.20 | 0.59 ± 0.12 | 1.93 ± 0.19 | 1.56 ± 0.14 | 0.80 ± 0.17 | 0.044 ± 0.021 | 0.42 ± 0.15 |
| 20 | 101 | 1.01 ± 0.13 | 1.15 ± 0.15 | 9.45 ± 0.82 | 0.59 ± 0.15 | 1.97 ± 0.14 | 1.50 ± 0.12 | 0.79 ± 0.17 | 0.039 ± 0.013 | 0.45 ± 0.18 | |
| 20 | 405 | 0.93 ± 0.09 | 1.12 ± 0.17 | 8.57 ± 1.29∗ | 0.55 ± 0.12 | 1.98 ± 0.17 | 1.51 ± 0.14 | 0.82 ± 0.11 | 0.045 ± 0.018 | 0.38 ± 0.16 | |
| 20 | 1620 | 0.87 ± 0.09∗∗ | 1.06 ± 0.23 | 7.32 ± 0.98∗∗ | 0.54 ± 0.09 | 1.85 ± 0.22 | 1.52 ± 0.16 | 0.76 ± 0.19 | 0.039 ± 0.015 | 0.30 ± 0.18∗ |
Compared with the control group. ∗: P < 0.05. ∗: P < 0.01.
Organ weights to brain (%)of S-D rats orally administrated with Rhubarb Extract for 52 weeks.
| Sex | Numbers of Animals | Dose | Brain | Heart | Lung | Liver | Spleen | Kidney | Ovaries/Testes | Uterus/Epididymides | Adrenals | Thymus |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Female | 20 | 0 | 1.94 ± 0.08 | 1.2 ± 0.11 | 1.47 ± 0.19 | 9.43 ± 0.80 | 0.64 ± 0.07 | 2.27 ± 0.17 | 0.17 ± 0.07 | 0.90 ± 0.16 | 0.11 ± 0.02 | 0.43 ± 0.16 |
| 20 | 101 | 1.92 ± 0.06 | 1.21 ± 0.17 | 1.69 ± 0.36 | 9.82 ± 1.72 | 0.72 ± 0.16 | 2.37 ± 0.25 | 0.17 ± 0.03 | 0.84 ± 0.18 | 0.11 ± 0.03 | 0.49 ± 0.24 | |
| 20 | 405 | 1.94 ± 0.09 | 1.19 ± 0.19 | 1.54 ± 0.18 | 9.39 ± 0.93 | 0.70 ± 0.11 | 2.37 ± 0.20 | 0.20 ± 0.05 | 0.85 ± 0.18 | 0.10 ± 0.02 | 0.36 ± 0.10 | |
| 19 | 1620 | 1.89 ± 0.16 | 1.13 ± 0.15 | 1.51 ± 0.22 | 8.74 ± 1.07 | 0.73 ± 0.10∗ | 2.41 ± 0.26 | 0.17 ± 0.03 | 0.85 ± 0.12 | 0.11 ± 0.02 | 0.30 ± 0.09∗ | |
| Male | 20 | 0 | 2.12 ± 0.08 | 2.10 ± 0.22 | 2.34 ± 0.30 | 19.9 ± 2.80 | 1.24 ± 0.23 | 4.08 ± 0.35 | 3.30 ± 0.26 | 1.71 ± 0.37 | 0.09 ± 0.04 | 0.90 ± 0.32 |
| 20 | 101 | 2.14 ± 0.08 | 2.16 ± 0.26 | 2.46 ± 0.32 | 20.23 ± 1.69 | 1.25 ± 0.31 | 4.21 ± 0.21 | 3.22 ± 0.24 | 1.70 ± 0.36 | 0.08 ± 0.02 | 0.97 ± 0.40 | |
| 20 | 405 | 2.18 ± 0.09 | 2.02 ± 0.15 | 2.43 ± 0.34 | 18.65 ± 2.68 | 1.19 ± 0.23 | 4.30 ± 0.30 | 3.28 ± 0.25 | 1.80 ± 0.27 | 0.10 ± 0.04 | 0.84 ± 0.33 | |
| 20 | 1620 | 2.14 ± 0.10 | 1.87 ± 0.22∗∗ | 2.26 ± 0.46 | 15.68 ± 2.12∗∗ | 1.15 ± 0.21 | 3.97 ± 0.48 | 3.24 ± 0.35 | 1.62 ± 0.41 | 0.08 ± 0.03 | 0.64 ± 0.40∗ |
Compared with the control group. ∗: P < 0.05. ∗: P < 0.01.
Histopathological findings of S-D rats orally observed administrated with Rhubarb Extract for 52 weeks.
| Organs and findings | Sex | Female | Male | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Dose (mg/kg) | 0 | 101 | 405 | 1620 | 0 | 101 | 405 | 1620 | |
| Number of animals | 20 | - | - | 19 | 20 | - | - | 20 | |
| Adrenal gland | Adrenal cortical cysticercosis | 0 | - | - | 1 | 0 | - | - | 0 |
| Adrenal cortical vacuolation | 0 | - | - | 0 | 2 | - | - | 1 | |
| Adrenal medullary hyperplasia | 1 | - | - | 0 | 1 | - | - | 0 | |
| Dilated adrenal sinus | 19∗∗ | - | - | 7 | 4 | - | - | 1 | |
| Pigmentation in adrenal gland | 0 | - | - | 0 | 0 | - | - | 1 | |
| Bladder | Deposition of proteinaceous material in bladder lumen | 0 | - | - | 0 | 0 | - | - | 2 |
| Epididymis | Epididymal epithelial vacuolation | - | - | - | - | 13 | - | - | 17 |
| Glandular stomach | Dilated gastric gland | 5 | - | - | 4 | 5 | - | - | 4 |
| Myocardial fibrosis | 1 | - | - | 1 | 9 | - | - | 3 | |
| Myocarditis cell infiltration | 3 | - | - | 0 | 6 | - | - | 4 | |
| Heart | Vacuolar degeneration, myocardial cell | 0 | - | - | 0 | 5 | - | - | 4 |
| Hypophysis | Anterior pituitary hyperplasia | 2 | - | - | 0 | 4 | - | - | 1 |
| Rathkes cyst | 0 | - | - | 0 | 0 | - | - | 1 | |
| Basophilia, tubular | 0 | - | - | 1 | 7 | - | - | 5 | |
| Hyaline tubular cast | 1 | - | - | 3 | 13 | - | - | 7 | |
| Hyperplasia, epithelial, renal pelvis | 1 | - | - | 0 | 1 | - | - | 0 | |
| Inflammation, mucosa, renal pelvis | 1 | - | - | 0 | 1 | - | - | 0 | |
| Renal calcium deposition | 6 | - | - | 0 | 0 | - | - | 0 | |
| Kidney | Renal interstitial inflammatory cell infiltration | 0 | - | - | 1 | 3 | - | - | 2 |
| Renal tubular pigment deposition | 0 | 0 | 10∗∗ | 19∗∗ | 0 | 0 | 13∗∗ | 20∗∗ | |
| Hepatic inflammatory cell infiltration | 0 | - | - | 1 | 1 | - | - | 0 | |
| Liver | Hepatocellular steatosis | 6∗ | - | - | 0 | 14 | - | - | 10 |
| Pulmonary interstitial inflammation | 0 | - | - | 1 | 0 | - | - | 0 | |
| Lung | Foam cell accumulation in lung | 3 | - | - | 3 | 2 | - | - | 0 |
| Ossification | 0 | - | - | 0 | 1 | - | - | 2 | |
| Dilated medullary sinus of lymph node | 0 | - | - | 2 | 1 | - | - | 0 | |
| Lymph node effusion | 0 | - | - | 2 | 1 | - | - | 0 | |
| Lymphnoditis | Phagocytosis of erythrocytes by macrophages | 1 | - | - | 0 | 0 | - | - | 0 |
| Mammary gland | Breast cyst | 0 | - | - | 1 | 0 | - | - | 0 |
| Lobular hyperplasia of mammary gland | 5 | - | - | 3 | 0 | - | - | 0 | |
| Ovary | Ovarian vesicle | 1 | - | - | 2 | - | - | - | - |
| Pancreas | Pancreatic atrophy | 0 | - | - | 0 | 0 | - | - | 2 |
| Pancreatic lipidation | 1 | - | - | 2 | 2 | - | - | 4 | |
| Thymic adipose tissue infiltration | 0 | - | - | 2 | 3 | - | - | 2 | |
| Thymus | Thymic atrophy | 2 | - | - | 4 | 9 | - | - | 8 |
| Thyroid gland | Dilated thyroid follicles | 1 | - | - | 0 | 1 | - | - | 0 |
| Thyroid follicular cell hyperplasia | 1 | - | - | 1 | 0 | - | - | 0 | |
| Vacuolar degeneration of thyroid follicular epithelial cells | 0 | - | - | 0 | 0 | - | - | 1 | |
| Uterus | Endometrial stromal polyp | 1 | - | - | 0 | - | - | - | - |
| Hyperplasia of uterine glandular epithelial cells | 1 | - | - | 1 | - | - | - | - | |
| Uterine cavity dilatation | 0 | - | - | 1 | - | - | - | - | |
| Uterine gland dilatation | 2 | - | - | 0 | - | - | - | - | |
| Uterine inflammatory cell infiltration | 2 | - | - | 1 | - | - | - | - | |
Compared with the control group. ∗: P < 0.05. ∗: P < 0.01.
Figure 20 mg/kg group(A); 101 mg/kg(B); 405 mg/kg(C); 1620 mg/kg(D); The arrow shows renal tubular pigment deposition.